[go: up one dir, main page]

BRPI0519022A2 - formaÇço insitu de implante para animais - Google Patents

formaÇço insitu de implante para animais

Info

Publication number
BRPI0519022A2
BRPI0519022A2 BRPI0519022-3A BRPI0519022A BRPI0519022A2 BR PI0519022 A2 BRPI0519022 A2 BR PI0519022A2 BR PI0519022 A BRPI0519022 A BR PI0519022A BR PI0519022 A2 BRPI0519022 A2 BR PI0519022A2
Authority
BR
Brazil
Prior art keywords
unsuitable
animal
training
animal implant
implant training
Prior art date
Application number
BRPI0519022-3A
Other languages
English (en)
Inventor
Caroline Sautter
Ute Isele
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0519022A2 publication Critical patent/BRPI0519022A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

FORMAÇçO INSITU DE IMPLANTE PARA ANIMAIS. A presente invenção refere-se a uma composição, compreendendo um polímero termoplástico, um agente de modificação de taxa e um agente biologicamente ativo, útil como um implante de liberação lenta do fármaco no corpo de um ser humano ou animal que pode ser administrada em forma liquida no corpo.
BRPI0519022-3A 2004-12-14 2005-12-13 formaÇço insitu de implante para animais BRPI0519022A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04029498 2004-12-14
PCT/EP2005/013377 WO2006063794A1 (en) 2004-12-14 2005-12-13 In-situ forming implant for animals

Publications (1)

Publication Number Publication Date
BRPI0519022A2 true BRPI0519022A2 (pt) 2008-12-23

Family

ID=34927750

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0519022-3A BRPI0519022A2 (pt) 2004-12-14 2005-12-13 formaÇço insitu de implante para animais

Country Status (16)

Country Link
JP (1) JP5372378B2 (pt)
KR (1) KR101304160B1 (pt)
CN (1) CN101056617B (pt)
AR (1) AR052155A1 (pt)
AT (1) ATE389386T1 (pt)
AU (1) AU2005315823B2 (pt)
BR (1) BRPI0519022A2 (pt)
CA (1) CA2585779C (pt)
DE (1) DE602005005522T2 (pt)
ES (1) ES2301084T3 (pt)
MX (1) MX2007007099A (pt)
NZ (1) NZ554904A (pt)
RU (1) RU2394558C2 (pt)
TW (1) TWI369218B (pt)
WO (1) WO2006063794A1 (pt)
ZA (1) ZA200703506B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
WO2008153611A2 (en) 2007-05-25 2008-12-18 Qlt Usa, Inc. Sustained delivery formulations of risperidone compounds
CN101159064B (zh) 2007-11-29 2010-09-01 腾讯科技（深圳）有限公司 画像生成系统以及按照图像生成画像的方法
US9877973B2 (en) 2008-05-12 2018-01-30 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US10588855B2 (en) 2008-05-12 2020-03-17 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US10064819B2 (en) 2008-05-12 2018-09-04 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
JP6543431B2 (ja) * 2013-10-10 2019-07-10 ユニバーシティー オブ ユタ リサーチ ファウンデーションＵｎｉｖｅｒｓｉｔｙ ｏｆ Ｕｔａｈ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ 眼内薬物送達デバイスおよび付随する方法
ES2971223T3 (es) 2017-04-13 2024-06-04 Ceva Sante Animale Implante para tratar infestaciones por parasitos
CN112336682B (zh) * 2020-09-28 2022-07-08 浙江大学 具有缓控释药物作用的可注射复合载体与组合物及制备方法
CN119677500A (zh) 2022-06-30 2025-03-21 维克公司 德舍瑞林在与pk/pd相互作用相关的非人类哺乳动物化学去势中的用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4938763B1 (en) * 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
WO1998027962A2 (en) * 1996-12-20 1998-07-02 Alza Corporation Injectable depot gel composition and method of preparing the composition
DE69917224T2 (de) * 1998-02-23 2004-09-09 Massachusetts Institute Of Technology, Cambridge Bioabbaubare polymere mit formgedächtnis
NZ506415A (en) * 1998-03-19 2003-06-30 Merck & Co Inc Liquid polymeric compositions for controlled release of bioactive substances using a polymer to active agent ratio of less than 1:1
US7128927B1 (en) * 1998-04-14 2006-10-31 Qlt Usa, Inc. Emulsions for in-situ delivery systems
JP4317606B2 (ja) * 1998-09-18 2009-08-19 サンスター株式会社 固体粒子形成用組成物
RU2355385C2 (ru) * 2002-11-06 2009-05-20 Алза Корпорейшн Композиции пролонгированного действия с контролируемым высвобождением
JP2007525429A (ja) * 2003-03-11 2007-09-06 キューエルティー ユーエスエー，インコーポレイテッド． 細胞スケジュール依存性抗癌剤のための処方

Also Published As

Publication number Publication date
JP5372378B2 (ja) 2013-12-18
CN101056617B (zh) 2012-07-11
MX2007007099A (es) 2007-06-22
KR101304160B1 (ko) 2013-09-04
DE602005005522D1 (de) 2008-04-30
JP2008523131A (ja) 2008-07-03
CA2585779A1 (en) 2006-06-22
NZ554904A (en) 2009-11-27
ATE389386T1 (de) 2008-04-15
CA2585779C (en) 2014-01-28
ZA200703506B (en) 2008-09-25
TW200635616A (en) 2006-10-16
AR052155A1 (es) 2007-03-07
TWI369218B (en) 2012-08-01
DE602005005522T2 (de) 2009-04-16
AU2005315823B2 (en) 2009-06-04
WO2006063794A1 (en) 2006-06-22
CN101056617A (zh) 2007-10-17
RU2394558C2 (ru) 2010-07-20
RU2007126759A (ru) 2009-01-27
ES2301084T3 (es) 2008-06-16
AU2005315823A1 (en) 2006-06-22
KR20070092964A (ko) 2007-09-14

Similar Documents

Publication Publication Date Title
AR111679A2 (es) Formulación farmacéutica de liberación controlada, procesos, usos, método
MD20070267A (en) Gastroresistant pharmaceutical formulation containing rifaximin
DE602004007555D1 (de) Implantat zur okklusion eines körperkanals
ATE355065T1 (de) Therapeutische zusammensetzungen bestehend aus antihypotensiva und antiangiogenika
WO2010039641A3 (en) Long term drug delivery devices with polyurethane-based polymers and their manufacture
CL2003002277A1 (es) Composicion farmaceutica inyectable, de deposito de liberacion prolongada, que comprende un agente beneficioso disuelto o disperso en un gel constituido por un polimero bioerosionable y biocompatible; y un solvente.
WO2019071243A8 (en) Implantable depots for the controlled release of therapeutic agents
ATE418325T1 (de) Zusammensetzungen für die lokalisierte therapie des auges, vorzugsweise enthaltend triamcinolon- acetonid und hyaluronsäure
CY1111465T1 (el) Εμφυτευσιμη πολυμερικη ιατροτεχνολογικη συσκευη για κατακρατημενη αποδεσμευση του αγωνιστη δοπαμινης
AR050118A1 (es) Composiciones orales y sistemas de liberacion
WO2007089544A3 (en) Biodegradable non-ophthalmic implants and related methods
ATE432689T1 (de) Arzneimittelformulierungen mit verzögerter freisetzung mit einem trägerpeptid
WO2007005716A3 (en) Methods of treatment and compositions for use thereof
EA201201569A1 (ru) Инъекционная композиция пролонгированного действия для введения антипсихотического препарата
ATE439123T1 (de) Verwendung von emulsionen zur intra- und periocularen injection
WO2014102613A3 (en) Device for disposal and neutralization of pharmaceutical agents
BRPI0519022A2 (pt) formaÇço insitu de implante para animais
DE602007004615D1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
GT200400218A (es) Formulaciones de liberacion sostenida.
MX2012000275A (es) Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal.
BRPI0415755A (pt) antagonistas do receptor b1 de bradiquinina
BRPI0512311A (pt) uso de meloxicam em medicina veterinária para o tratamento de doenças inflamatórias dolorosas
TN2012000194A1 (en) Antifungal mixture with fungal organism pythium oligandrum
BR112013010829B8 (pt) Composição farmacêutica intravenosa para proporcionar alívio da dor e/ou da inflamação
EP1781277A4 (en) COMBINATION PREPARATION

Legal Events

Date Code Title Description
B25C Requirement related to requested transfer of rights

Owner name: NOVARTIS AG (CH)

Free format text: A FIM DE ATENDER A TRANSFERENCIA REQUERIDA ATRAVES DA PETICAO NO 20150005919 DE 23/03/2015 , E NECESSARIO REAPRESENTAR O DOCUMENTO DE CESSAO COM AS ASSINATURAS NOTARIZADAS E A DEVIDA LEGALIZACAO CONSULAR.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 11A ANUIDADE.

B25B Requested transfer of rights rejected

Owner name: NOVARTIS AG (CH)

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]